Clinical Trial Update: High-Intensity, Brief-Duration Chemotherapy in Treating Patients With Relapsed or Refractory Acute Lymphocytic Leukemia [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating high-intensity, brief-duration chemotherapy in relapsed or refractory acute lymphocytic leukemia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lymphocytic Leukemia

Snippet

Sponsor: Wake Forest University Health Sciences | Conditions: Leukemia | Phase 2 | Status: COMPLETED